Immunohistochemistry analysis for phospho-STAT3 (Tyr 705) and SHP-2 in subcutaneous tumor showed strong expression of SHP-2 and reciprocal decrease in phospho-STAT3 by ciglitazone (Figure 5D). The gene discussed is PTPN11; the disease is neoplasm.